Dr. Rachel Roditi, MD
- Medicare services, 2024
- 454
- Medicare patients, 2024
- 162
- Part D claims, 2024
- 128
- Publications
- 29
- Hospital affiliations
- 2
- Practice address
- 75 Francis Street, Boston, MA 02115
- Practice phone
- Call (617) 732-5500
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Roditi's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Rachel Roditi is an otolaryngologist in Boston, Massachusetts
Dr. Roditi practices at Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham.
Dr. Roditi's NPI, 1417129644, was assigned on March 27, 2008. Dr. Roditi graduated from University of Massachusetts Medical School in 2008. Dr. Roditi holds Massachusetts license 255175.
- NPI
- 1417129644NPI Registry (opens in a new tab)
- Medicare PAC ID
- 1153565957
- NPI enumeration date
- March 27, 2008
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (617) 732-5500
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 44
- Medical school graduation
- 2008
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Rachel Roditi practices at Brigham and Women's Hospital in Boston, Massachusetts
Dr. Roditi's primary practice is Brigham and Women's Hospital, at 75 Francis Street, Boston, MA 02115 in Suffolk County. The practice phone is (617) 732-5500.
- Brigham and Women's Hospital75 Francis Street, Boston, MA 02115 · Suffolk CountyPhone(617) 732-5500
Source: Dmand AI Affiliation Data
Dr. Rachel Roditi is affiliated with 3 sites of care and 2 medical groups
Dr. Roditi's primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Roditi is also affiliated with Brigham and Women's Faulkner Hospital. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Dr. Roditi to 1 more hospital outpatient department and 1 medical group, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Rachel Roditi's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Roditi practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Brigham and Women's Hospital | Available with a free account |
| +2 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Mass General Brigham and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Rachel Roditi is one of 308 otolaryngologists in Massachusetts
Otolaryngology is Dr. Roditi's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Roditi is licensed in Massachusetts.
Specialties and state licenses
- Otolaryngology, MassachusettsPrimary
Otolaryngologists near Dr. Roditi
Counts of otolaryngologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Rachel Roditi billed Medicare for 454 services in 2024
CMS data shows 454 Medicare services from Dr. Roditi across 6 procedure codes in 2024, for 162 Medicare patients. Medicare paid $69,465 for them. Every service was in an office.
Dr. Roditi's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 2382024: 26110%
- Surgery
- 2023: 1872024: 1933%
Dr. Roditi compared with the Massachusetts median for otolaryngologists, 2024
- Dr. Roditi
- Massachusetts median
- Medicare services
- 454vs 74439% below
- Medicare patients
- 162vs 36355% below
- Part D claims
- 84vs 896% below
Medians across 303 otolaryngologists in Massachusetts with Dmand AI profiles that report each measure.
Dr. Roditi's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Roditi?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Roditi and other otolaryngologists in Massachusetts.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Rachel Roditi treated 162 Medicare patients in 2024, average age 72
CMS counts 162 Medicare patients who saw Dr. Roditi in 2024. The largest group is 65 to 74, with 80 patients. 72% of them have high cholesterol, and 60% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Dr. Roditi's median patient age at 55, with 56% women.
Dr. Roditi's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Roditi's Medicare patients by sex, 2024
- Women9357%
- Men6943%
Chronic conditions among Dr. Roditi's Medicare patients, 2024
- High cholesterol72%
- High blood pressure60%
- Arthritis46%
- Anxiety30%
- Mood disorders29%
- Diabetes28%
- Asthma27%
- Depression25%
Share of Medicare patients with each condition. A patient can have several.
Dr. Roditi's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 55
Patient panel by sex, all payers
- Women56%
- Men44%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Rachel Roditi wrote 128 Medicare Part D claims in 2024
In 2024, Dr. Roditi wrote 128 Medicare Part D claims for 57 patients. 98% of them were for generic drugs. CMS names the drug for 84 of them, across 3 drugs with 11 or more claims each, at $1,373 in total drug cost. In 2023, CMS named 85 claims across 3 drugs.
Dr. Roditi's Part D claims by kind of drug, 2024
- Generic125 claims98%
- Brand-name and other3 claims2%
Dr. Roditi's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 852024: 841%
Drugs named by CMS: 3 in 2024, 3 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Rachel Roditi offers telehealth to Medicare patients
Dr. Roditi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Roditi as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Rachel Roditi has 29 publications on record
Dmand AI links 29 papers to Dr. Roditi, published from 2012 to 2025. 2023 was the busiest year, with 6. The most frequent topics are Nasal Polyps, Rhinitis and Sinusitis. Dr. Roditi has published most often in Int Forum Allergy Rhinol. Dr. Roditi's most frequent co-authors are Kathleen Mary Buchheit, MD, Regan W. Bergmark, MD and Alice Z. Maxfield, MD.
Dr. Roditi's papers by year, 2016 to 2025
Topics Dr. Roditi writes about most
- Nasal Polyps
- Rhinitis
- Sinusitis
- Asthma, Aspirin-Induced
- Cell Proliferation
- Aspirin
- Otitis Media with Effusion
- Quality Improvement
Dr. Roditi's most frequent co-authors
- Kathleen Mary Buchheit, MD11 shared papers
- Regan W. Bergmark, MD9 shared papers
- Alice Z. Maxfield, MD8 shared papers
Recent publications by Dr. Roditi
J Allergy Clin Immunol
See who Dr. Roditi researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Roditi works with, so you can find a warm path to the right otolaryngologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Rachel Roditi received $1,621 in industry payments from 2016 to 2019
CMS Open Payments shows 11 general payments to Dr. Roditi from 3 drug and device companies from 2016 to 2019. Food and beverage make up the largest share, 58% of the total. Genentech, Inc. paid the most, $980.
General payments to Dr. Roditi by program year, 2016 to 2019
General payments to Dr. Roditi by kind, 2016 to 2019
- Food and beverage$94058%
- Travel and lodging$68142%
Companies that paid Dr. Roditi the most, 2016 to 2019
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Rachel Roditi graduated from University of Massachusetts Medical School
Dr. Roditi graduated from University of Massachusetts Medical School in 2008.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Rachel Roditi's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Rachel Roditi
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Rachel Roditi's NPI number?
Dr. Rachel Roditi's NPI number is 1417129644. It was assigned on March 27, 2008, and it is active in the NPI Registry.
What kind of doctor is Dr. Rachel Roditi?
Dr. Rachel Roditi is an otolaryngologist in Boston, Massachusetts. The primary specialty in the NPI Registry is Otolaryngology Physician (taxonomy code 207Y00000X).
Where does Dr. Rachel Roditi practice?
Dr. Roditi practices at 75 Francis Street, Boston, MA 02115. Dr. Roditi's primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. Dmand AI also links Dr. Roditi to 1 hospital outpatient department and 1 medical group.
What is Dr. Rachel Roditi's office phone number?
The practice phone on file for Dr. Roditi is (617) 732-5500.
What is Dr. Rachel Roditi's medical license number?
Dr. Roditi holds Massachusetts license 255175.
Which hospitals is Dr. Rachel Roditi affiliated with?
Dr. Roditi practices at Brigham and Women's Hospital in Boston, Massachusetts. Dr. Roditi is also affiliated with Brigham and Women's Faulkner Hospital.
What medical group is Dr. Rachel Roditi part of?
Dr. Roditi is linked to Brigham and Women's Hospital. Dmand AI links Dr. Roditi to 1 more medical group.
Does Dr. Rachel Roditi accept Medicare?
Yes. CMS data shows Dr. Roditi billed Medicare for 454 services in 2024, and Dr. Roditi accepts Medicare assignment.
Does Dr. Rachel Roditi offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Roditi as offering telehealth services.
How many Medicare patients does Dr. Rachel Roditi see?
CMS counts 162 Medicare patients who saw Dr. Roditi in 2024, with an average age of 72.
Show 7 more questionsShow fewer questions
What services does Dr. Rachel Roditi bill to Medicare?
In 2024, Dr. Roditi's most billed Medicare services were office visit, established patient (99215), surgery: lungs and airway (31231) and office visit, new patient (99205).
Where did Dr. Rachel Roditi go to medical school?
Dr. Roditi graduated from University of Massachusetts Medical School in 2008.
What drugs does Dr. Rachel Roditi prescribe most?
In 2024 Medicare Part D data, Dr. Roditi's most prescribed drugs by claims were Ipratropium Bromide, Mupirocin and Azelastine HCl.
Has Dr. Rachel Roditi received payments from drug or device companies?
CMS Open Payments shows $1,621 in general payments to Dr. Roditi from 3 companies from 2016 to 2019. The largest total came from Genentech, Inc.
How long has Dr. Rachel Roditi been practicing?
Dr. Roditi graduated from medical school in 2008, 18 years ago.
Does Dr. Rachel Roditi do research?
Dmand AI links 29 publications to Dr. Roditi, published from 2012 to 2025.
Who does Dr. Rachel Roditi publish with?
Dr. Roditi's most frequent co-authors are Kathleen Mary Buchheit, MD (11 shared papers), Regan W. Bergmark, MD (9 shared papers) and Alice Z. Maxfield, MD (8 shared papers).
Selling to otolaryngology practices?
See otolaryngologists in Massachusetts by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card